ANNVILLE, Pa.--(BUSINESS WIRE)--Oct 27, 2023--L2P Research, LLC, a leading preclinical CRO, today announced the award of a <em>Phase I Small Business Innovation Research (SBIR) grant from the</em><a ...
IRVINE, Calif.--(BUSINESS WIRE)--Oct 27, 2023--<a ...
HOUSTON--(BUSINESS WIRE)--Oct 27, 2023--<a ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Oct 27, 2023--Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will report third quarter 2023 financial results on Thursday, November 2 nd, 2023. Mirum will also host a conference call to discuss the third quarter 2023 financial results ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Oct 27, 2023--<a ...
DUBLIN--(BUSINESS WIRE)--Oct 27, 2023--The <a ...